Cargando…

F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2

BACKGROUND: Prostaglandin (PG) F(2α )is a key regulator of endometrial function and exerts its biological action after coupling with its heptahelical G protein-coupled receptor (FP receptor). In endometrial adenocarcinoma the FP receptor expression is elevated. We have shown previously that PGF(2α)-...

Descripción completa

Detalles Bibliográficos
Autores principales: Keightley, Margaret C, Brown, Pamela, Jabbour, Henry N, Sales, Kurt J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824741/
https://www.ncbi.nlm.nih.gov/pubmed/20092633
http://dx.doi.org/10.1186/1471-2121-11-8
_version_ 1782177730768404480
author Keightley, Margaret C
Brown, Pamela
Jabbour, Henry N
Sales, Kurt J
author_facet Keightley, Margaret C
Brown, Pamela
Jabbour, Henry N
Sales, Kurt J
author_sort Keightley, Margaret C
collection PubMed
description BACKGROUND: Prostaglandin (PG) F(2α )is a key regulator of endometrial function and exerts its biological action after coupling with its heptahelical G protein-coupled receptor (FP receptor). In endometrial adenocarcinoma the FP receptor expression is elevated. We have shown previously that PGF(2α)-FP receptor signalling in endometrial adenocarcinoma cells can upregulate several angiogenic factors including fibroblast growth factor-2 (FGF2). In the present study, we investigated the paracrine effect of conditioned medium produced via PGF(2α)-FP receptor signalling in endometrial adenocarcinoma cells stably expressing the FP receptor (Ishikawa FPS cells), on endothelial cell function. RESULTS: Conditioned medium (CM) was collected from FPS cells after 24 hrs treatment with either vehicle (V CM) or 100 nM PGF(2α )(P CM). Treatment of human umbilical vein endothelial cells (HUVECs) with P CM significantly enhanced endothelial cell differentiation (network formation) and proliferation. Using chemical inhibitors of intracellular signalling, we found that P CM-stimulated endothelial cell network formation was mediated by secretion of endothelial PGF(2α )and activation of endothelial FP receptors, following FGF2-FGFR1 signalling, phosphorylation of ERK1/2 and induction of COX-2. Whereas, P CM stimulation of endothelial cell proliferation occurred independently of PGF(2α )secretion via an FGF2-FGFR1-ERK1/2 dependent mechanism involving activation of the mTOR pathway. CONCLUSIONS: Taken together, we have shown a novel mechanism whereby epithelial prostaglandin F(2α)-FP signalling regulates endothelial cell network formation and proliferation. In addition we provide novel in vitro evidence to suggest that prostaglandin F(2α )can directly regulate endothelial cell network formation but not endothelial cell proliferation. These findings have relevance for pathologies where the FP receptor is aberrantly expressed, such as endometrial adenocarcinoma, and provide in vitro evidence to suggest that targeting the FP receptor could provide an anti-angiogenic approach to reducing tumour vasculature and growth.
format Text
id pubmed-2824741
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28247412010-02-20 F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2 Keightley, Margaret C Brown, Pamela Jabbour, Henry N Sales, Kurt J BMC Cell Biol Research article BACKGROUND: Prostaglandin (PG) F(2α )is a key regulator of endometrial function and exerts its biological action after coupling with its heptahelical G protein-coupled receptor (FP receptor). In endometrial adenocarcinoma the FP receptor expression is elevated. We have shown previously that PGF(2α)-FP receptor signalling in endometrial adenocarcinoma cells can upregulate several angiogenic factors including fibroblast growth factor-2 (FGF2). In the present study, we investigated the paracrine effect of conditioned medium produced via PGF(2α)-FP receptor signalling in endometrial adenocarcinoma cells stably expressing the FP receptor (Ishikawa FPS cells), on endothelial cell function. RESULTS: Conditioned medium (CM) was collected from FPS cells after 24 hrs treatment with either vehicle (V CM) or 100 nM PGF(2α )(P CM). Treatment of human umbilical vein endothelial cells (HUVECs) with P CM significantly enhanced endothelial cell differentiation (network formation) and proliferation. Using chemical inhibitors of intracellular signalling, we found that P CM-stimulated endothelial cell network formation was mediated by secretion of endothelial PGF(2α )and activation of endothelial FP receptors, following FGF2-FGFR1 signalling, phosphorylation of ERK1/2 and induction of COX-2. Whereas, P CM stimulation of endothelial cell proliferation occurred independently of PGF(2α )secretion via an FGF2-FGFR1-ERK1/2 dependent mechanism involving activation of the mTOR pathway. CONCLUSIONS: Taken together, we have shown a novel mechanism whereby epithelial prostaglandin F(2α)-FP signalling regulates endothelial cell network formation and proliferation. In addition we provide novel in vitro evidence to suggest that prostaglandin F(2α )can directly regulate endothelial cell network formation but not endothelial cell proliferation. These findings have relevance for pathologies where the FP receptor is aberrantly expressed, such as endometrial adenocarcinoma, and provide in vitro evidence to suggest that targeting the FP receptor could provide an anti-angiogenic approach to reducing tumour vasculature and growth. BioMed Central 2010-01-21 /pmc/articles/PMC2824741/ /pubmed/20092633 http://dx.doi.org/10.1186/1471-2121-11-8 Text en Copyright ©2010 Keightley et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Keightley, Margaret C
Brown, Pamela
Jabbour, Henry N
Sales, Kurt J
F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2
title F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2
title_full F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2
title_fullStr F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2
title_full_unstemmed F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2
title_short F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2
title_sort f-prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824741/
https://www.ncbi.nlm.nih.gov/pubmed/20092633
http://dx.doi.org/10.1186/1471-2121-11-8
work_keys_str_mv AT keightleymargaretc fprostaglandinreceptorregulatesendothelialcellfunctionviafibroblastgrowthfactor2
AT brownpamela fprostaglandinreceptorregulatesendothelialcellfunctionviafibroblastgrowthfactor2
AT jabbourhenryn fprostaglandinreceptorregulatesendothelialcellfunctionviafibroblastgrowthfactor2
AT saleskurtj fprostaglandinreceptorregulatesendothelialcellfunctionviafibroblastgrowthfactor2